Here are six notes:
1. The market will likely surpass $1.7 billion by 2022.
2. A growing geriatric population and increasing demand for minimally invasive procedures will boost market growth.
3. The knee application dominates the arthroscopy market, capturing one third of the market share through 2022.
4. The hip arthroscopy segment generates the greatest revenue behind knee, followed by spine arthroscopy.
5. Key market players include Arthrex, Stryker, CONMED, Smith & Nephew, Zimmer Biomet, Medtronic, Wright Medical Group and Richard Wolf.
6. Hospitals will continue to serve as the dominant end-user of arthroscopic devices.
More articles on devices:
OrthoPediatrics launches 24th surgical system: 3 things to know
Arthrex beings headquarter expansion, to add 500+ jobs
Zyga’s SImmetry SI Joint Fusion System clinical trial shows reduction in back pain, opioid dependency: 5 insights
